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Abstract
Objectives—Hyperglycemia has been associated with an increased risk of cardiovascular
morbidity and mortality. Although numerous studies have demonstrated that hyperglycemia is
associated with the atherosis component of atherosclerosis, limited studies have addressed the
independent role of hyperglycemia in the pathophysiology of sclerotic vascular disease. We
hypothesized that hyperglycemia, as assessed by hemoglobin A1c (HbA1c), would be
independently associated two common indices of arterial stiffness (pressure-strain elastic modulus
(Ep) and Young’s elastic modulus (YEM)).
Methods—We examined the cross-sectional association between HbA1c and arterial stiffness
using B-mode ultrasound examination of the carotid artery in 9,050 participants from the
community-based Atherosclerosis Risk in Communities (ARIC) Study. We used multivariable
linear and logistic regression models to characterize the association between HbA1c and increased
Ep and YEM.
Results—Higher values of HbA1c were associated in a graded fashion with increased arterial
stiffness (P-trend <0.001 for both EP and YEM). After adjusting for traditional risk factors,
increasing HbA1c deciles were significantly associated with elevated EP (OR for the highest
decile of HbA1c compared to the lowest, 2.01, 95% CI 1.30, 3.11) and YEM (OR = 1.71, 95% CI
1.15, 2.55).
Conclusion—Elevated HbA1c is associated with measures of increased arterial stiffness, even
after accounting for arterial wall thickness. This is consistent with the hypothesis that
hyperglycemia contributes to arterial stiffness beyond its effects on atherosis and suggests that
hyperglycemia is associated with altered material within the arterial wall.
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Introduction
In the United States an estimated 5.4 million individuals have been diagnosed with diabetes
and around 2.4 million are undiagnosed 1. Diabetes is associated with early and accelerated
atherosclerosis, and heart disease death rates among adults with diabetes are 2 to 4 times
higher than for those without diabetes. Diabetes affects the vasculature by various
mechanisms; “atherosis” is a term which has been used to refer to lipid deposition in the
vasculature to form intimal plaques while sclerosis refers to “vessel stiffening” 2. Although
most studies have shown positive associations between hyperglycemia and arterial stiffness
among persons with diabetes 3–9, there is inconclusive evidence among persons with
impaired fasting glucose or impaired glucose tolerance 8, 9. Because atherosis and sclerosis
typically coexist in vivo, the isolation of the arterial sclerotic component is difficult.
Although numerous studies have demonstrated that hyperglycemia is associated with the
atherosis (lipid) component of atherosclerosis, and have addressed the independent role of
hyperglycemia in the pathophysiology of sclerotic vascular disease in diabetes, there are
limited and conflicting data in the general population 2
Although different methods exist for quantifying the elastic properties of arteries, pressure-
strain elastic modulus (Ep) and Young’s elastic modulus (YEM) provide useful and
complementary information 10. While the two measures are similar, YEM incorporates the
ratio of arterial wall thickness to radius and the circumferential arterial strain to estimate the
degree of arterial wall stiffness 10, 11
The objective of this study was to examine the relationship between hyperglycemia–as
assessed by glycated hemoglobin (HbA1c)- and measures of increased arterial stiffness in
diabetics and non-diabetics in the Atherosclerosis Risk in Communities (ARIC) cohort.
Furthermore, we sought to determine the arterial wall thickness-independent association of
hyperglycemia and arterial stiffness with the use of an index that does and one that does not
adjust for arterial wall thickness (YEM and EP, respectively).
Methods
Study Population
The ARIC Study is a prospective, community-based study of the natural history of
atherosclerotic disease. The initial sample consisted of 15,792 men and women aged 45 to
64 years from four US communities: Forsyth County, North Carolina; suburban
Minneapolis, Minnesota; Washington County, Maryland; and Jackson, Mississippi.
Institutional review boards at participating institutions approved the study and informed
consent was obtained from all subjects. Details of the study design and examination
procedures have been previously described 12. Briefly, the baseline visit took place between
1987–89 (visit 1) and the first follow up examination took place in 1990–1992 (visit 2).
Arterial stiffness indexes were assessed during visit 2 in 10,187 participants (71% of those
who attended visit 2). We excluded individuals with missing HbA1c values (n=198), less
than 2 EKG cycles available at the time of the ultrasound exam (n=730), self-reported race
other than black or white (n= 32), or missing covariate data (n=177) for a final study sample
of 9,050 participants with complete data.
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Age, sex, race, alcohol use and smoking status were ascertained from interviews during visit
2. History of diabetes was defined as a self-reported physician diagnosis of diabetes or use
of glucose lowering medication at either the first or second ARIC examination. Trained
examiners measured weight and height. Serum creatinine concentration was measured using
a modified kinetic Jaffe method. Estimated glomerular filtration rate was calculated using
the Modification of Diet in Renal Disease Study equation. Serum glucose was measured by
the hexokinase method and HbA1c was measured from frozen whole blood samples from
ARIC visit 2 using a high performance liquid chromatography instrument (Tosoh
Corporation, Tokyo, Japan).
Ultrasound exam
Data from the visit 2 ultrasound examination was collected as previously described 10.
Briefly, after participants rested in the supine position for 20 minutes, a centrally trained and
certified sonographer used non-invasive B-mode ultrasound to collect arterial diameter data
from the left common carotid artery. Data was digitized by an analog to digital converter
and then sent to an ultrasound-reading center where arterial diameter data was estimated as
the average over the cardiac cycles available (average = 5.6 cycles). The diastolic arterial
diameter (DAD) and the arterial diameter change (ADC) between systole and diastole from
the left carotid artery during cardiac cycles were used for this analysis. Pulse Pressure (PP)
was calculated as the systolic blood pressure – diastolic blood pressure. Concurrent resting
brachial blood pressure was measured every 5 minutes with an automated oscillometric
device (1846SX Dinamap), and the mean of 2 BP measures before the completion of
ultrasound examination was used in calculating arterial stiffness indices. From these
diameter and BP data, the following parameters were estimated:
Peterson’s elastic modulus 13 (Ep) = (PP × DAD)/ADC (kPa)
Young’s elastic modulus (YEM) 10 = (Ep × DAD)/(2 × IMT)] (kPa)
Higher values of both Ep and YEM indicate greater arterial stiffness 10, 13. The reliability
coefficient was 0.66 for EP 14 and 0.38 for YEM.
Statistical Analysis
HbA1c was modeled continuously and by deciles. The characteristics of the study
population were compared across HbA1c deciles. We conducted analyses using
multivariable logistic regression to assess the association between increasing deciles of
HbA1c and arterial stiffness (highest decile of EP and YEM) with adjustment for covariates.
We implemented three models for the adjustment of covariates. Model 1 was adjusted for
age, gender, center and race; Model 2 was further adjusted for height, weight, education,
smoking, LDL and HDL-cholesterol and diabetes history; Model 3 was further adjusted for
mean arterial pressure measured at the time of the ultrasound exam. We tested for
interaction by age, race, and sex. We also performed analysis restricted to persons without a
history of diabetes. All analyses were conducted using STATA 11.1 (Stata Corp, College
Station, TX) and a P-value of <0.05 was considered statistically significant.
Results
Baseline characteristics according to HbA1c deciles are listed in Table 1. Mean age was
56.7 years and 57% of participants were female. Participants with higher HbA1c were more
likely to be African American, have hypertension, have higher BMI and LDL-cholesterol
levels and lower HDL-cholesterol levels. Participants in the higher deciles of HbA1c were
also more likely to have increased arterial stiffness parameters (Ep and YEM). Ep and YEM
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were highly correlated (Spearman’s correlation coefficient=0.86). There were 788
participants with diabetes.
Table 2 shows the characteristics of participants with increasing quartiles of EP. Most
notably, participants with the highest stiffness indexes (highest EP quartile) were more
likely to be hypertensive and non-smokers. They also had higher HbA1c and BMI and were
more likely to be African Americans and older.
The continuous association between HbA1c and arterial stiffness measures is shown in
Table 3. Baseline HbA1c was positively associated with arterial stiffness measures. In the
analysis adjusted for age, gender, race and field center, every 1-percentage point higher
HbA1c value was associated with higher value of EP (β=7.89; 95% CI=6.74, 9.03) and
YEM (β=37.33; 95% CI=27.54, 44.01). This association remained significant after
additional adjustment for other cardiovascular risk factors (Model 2) and concurrently-
measured mean arterial pressure (β for EP=3.91; 95% CI=2.57, 5.26 and β for YEM=13.50;
95% CI=3.10, 23.90).
Table 4 shows the odds ratios (ORs) for the highest EP and YEM decile in relation to
HbA1c deciles. In age, gender, race, and field center adjusted analyses, increasing HbA1c
deciles were significantly associated with elevated EP (OR for the highest decile of HbA1c
compared to the lowest, 3.11; 95% CI 2.17, 4.48). The association remained significant after
adjusting for other cardiovascular risk factors (Model 2, OR= 1.93, 95% CI 1.29, 2.89) and
after further adjustment for mean arterial pressure (Model 3, OR 2.01, 95% CI 1.30, 3.11).
Adjustment for SBP rather than MAP did not appreciably alter our results (results not
shown).
In age, gender, race, and field center adjusted analyses, increasing HbA1c deciles were also
associated with elevated YEM (OR for the highest decile of HbA1c compared to the lowest
=2.34; 95% CI 1.67, 3.28) (Table 4). The association remained significant after adjustment
for cardiovascular risk factors (OR = 1.70, 95% CI 1.16, 2.49) and further adjustment for
mean arterial pressure (Model 3, OR 1.71 1.15, 2.55).
The results were consistent when analysis was restricted to persons without a history of
diabetes (online appendix). There was no evidence that gender, race, age or history of
diabetes, modified the association between HbA1c and elevated EP and YEM (P>0.20 for
all interactions).
Discussion
In a community-based study of 9,050 individuals without clinically evident coronary heart
disease, we found that hyperglycemia was independently associated with measures of
increased arterial wall stiffness. Our results also demonstrate that hyperglycemia is
associated with a measure of arterial stiffness that incorporates arterial wall thickness, which
may suggest that hyperglycemia is associated with altered material within the arterial wall.
Stiffness measures adjusted for blood pressure, particularly when measured concurrently
with the stiffness assessment as done here, may relate more closely to inherent
characteristics of the arterial wall. Our models adjusted for blood pressure and furthermore
pulse pressure is used for the estimation of both EP and YEM. Despite these adjustments,
hyperglycemia remained associated with stiffness. This, together with the fact that the
hyperglycemia associations were found with both Ep and YEM contribute to evidence that
the effect glycemia on stiffness is due in large part to altered material within the arterial
wall, not to wall thickness or its reaction to increased blood pressure.
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Cardiovascular disease is the leading cause of morbidity and mortality in persons with
diabetes mellitus. Although risk factors present in persons with diabetes (e.g. obesity,
hypertension) partially explain the increased cardiovascular risk observed among persons
with diabetes, hyperglycemia remains an independent risk factor for cardiovascular disease
morbidity and mortality 15. Arterial stiffness has been associated with adverse
cardiovascular events in the general population as well. In a meta-analysis of 17 studies 16
Vlachopoulos et al have demonstrated that regional arterial stiffness (i.e. pulse wave
velocity) is associated with cardiovascular events, and, cardiovascular and all-cause
mortality. In the ARIC study 17 local arterial stiffness (measured through carotid ultrasound
as in the current analysis) has been shown to be associated with stroke but not coronary
heart disease. Our study by demonstrating an association between hyperglycemia and
arterial stiffness suggests that hyperglycemia-associated arterial stiffness may partially
contribute to the increased cardiovascular risk observed among persons chronically exposed
to elevated glucose levels.
Our data are consistent with previous studies demonstrating that elevated fasting glucose
concentrations are positively associated with arterial stiffness measures 3, 9, 18. Using
biomechanical techniques to estimate arterial stiffness parameters from pathological
specimens from 27 subjects, Oxlund et al showed that those with diabetes had decreased
vessel wall distensibility in areas without atherosclerotic plaque 18. Interestingly, they
suggested that this was due to changes in the connective tissue of arteries that was
independent of atherosclerosis and suggested that this may be due to non-enzymatic
glycation of proteins. Because they only excluded atherosclerotic plaques visually they were
unable to provide a reliable estimate of the atherosis-independent stiffness association.
In a study of 747 older and predominately white persons, Henry et al. evaluated the
association between impaired glucose metabolism, diabetes and increased arterial stiffness 9.
Although Henry et al. demonstrated an association between hyperglycemia and most
stiffness measures among persons with diabetes, they did not observe any associations
among participants with impaired glucose metabolism (composite of IFG and IGT). By
contrast, we found that hyperglycemia was significantly associated with YEM, even below
threshold for diagnosis of diabetes (i.e. HbA1c <6.5%).
Using data from the first ARIC examination, Salomaa et al. showed using models adjusted
for age, smoking and total cholesterol, that persons with non-insulin dependent diabetes or
impaired fasting glucose had stiffer arteries than persons with fasting glucose values in the
normal range 3. In models further adjusted for other cardiovascular risk factors this
association was no longer significant in most subgroups. After further adjusting for other
cardiovascular risk factors, EP and YEM only remained significant in some gender-race
subgroups.
Although we did not formally perform test to identify a HbA1c threshold for stiffness, it is
worth noting that our study showed that hyperglycemia was associated with increased
arterial stiffness as assessed by EP from the eighth decile of glycated hemoglobin (HbA1c =
5.7–5.8%) and by YEM from the highest decile (HbA1c ≥6.3%). These values are below the
current diagnosis threshold for diabetes 19, and our findings accord with other studies that
have demonstrated that hyperglycemia, even below the diagnosis threshold for diabetes, is
associated to increased cardiovascular risk 20.
Advanced glycation endproducts (AGEs) are a mechanism by which chronic hyperglycemia
may contribute to arterial stiffness. Thirty years ago Monnier et al. postulated that non-
enzymatic glycation (Maillard reaction) was associated with protein aging 21. Numerous
studies have since demonstrated associations between measures of glycation products and
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complications of diabetes mellitus. Chronic hyperglycemia enhances the reaction between
glucose and proteins and facilitates cross-linking of collagen, elastin and other molecules
commonly referred to as advanced glycation end products 22. Similar to their effect on
glycated hemoglobin (HbA1c), elevated levels of glucose are associated with the non-
enzymatic glycation of other proteins in skin, vasculature and lens collagen, and have also
been demonstrated to promote collagen deposition, tissue inflammation and fibrosis.
Although we are unable to establish temporality in our study, we can speculate that the
observed association between hyperglycemia and arterial stiffness is causal, mediated by
advanced glycation end products.
In vitro studies have suggested that hyperglycemia affects the arterial wall by stimulating the
proliferation of smooth muscle cells 23 and the non-enzymatic glycosylation of proteins 24.
Advanced glycation end products are associated with arterial stiffness and hypertension in
humans 25. The administration of a chemical that break advanced glycation end product
cross-links has been shown to reverse arterial and myocardial stiffness in rhesus monkeys 26.
In a recent study of older individuals with vascular stiffening, Kass et al. showed that using
an advanced glycation end-product crosslink breaker improved arterial compliance in
humans with vascular stiffening 27. However recent evidence suggests that there is no
relationship between crosslink breaks and arterial stiffness 28.
B-mode ultrasound assessment of the arterial wall thickness has been used as a surrogate
marker of atherosclerosis and has also been associated to future cardiovascular events 29, 30.
It is important to point out that because atherosis and sclerosis typically coexist in vivo,
there is no way to reliably obtain a measure of stiffness that is entirely independent of
atherosis. Furthermore, some have questioned the accuracy of arterial wall thickness as a
reliable measure of atherosis 31 as clearly several other factors contribute to the thickening
of the intima-medial complex. However, atherosis is a sub-intimal process and therefore
accounting for the arterial wall thickness (as done for YEM), while imperfect, may represent
one of the best surrogate approaches to account for local atherosis in a large population-
based study.
We found that elevated HbA1c was associated with increased arterial stiffness using two
different measures: YEM and Ep. Prior evidence suggests that YEM is less precise the Ep
due to added variability from inclusion of wall thickness 32. This was also observed in our
study in that the reliability coefficient of YEM was less than Ep. Despite YEM’s decreased
precision, we found that Hba1c was much more strongly associated with YEM than Ep
(Table 3), which may suggest an even stronger link between hyperglycemia and arterial wall
thickness than frequently observed by measures that do not incorporate wall thickness.
Our study contributes to the field by providing evidence in a large well characterized
population that hyperglycemia (as measured by HbA1C) is associated with arterial stiffness.
A major strength of our study was the assessment of hyperglycemia by HbA1c, a marker of
long-term glycemic exposure that has recently been recommended as a diagnostic test for
diabetes mellitus 19. Additionally we tried to account for the arterial thickness (and hence
partially the atherosis component) which is factored in the determination of YEM 10,
Therefore our results suggest that hyperglycemia leads to increased arterial stiffness even
after accounting for blood pressure and arterial thickness.
Limitations
Arterial stiffness parameters used for the calculation of EP and YEM were measured at the
carotid artery but blood pressure used in the calculations was measured from the brachial
artery, and this may result in the overestimation of the central blood pressure. However,
studies have shown an excellent correlation between central and brachial blood pressure
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measurements 33 and most epidemiological studies use brachial artery blood pressures in the
estimation of carotid artery stiffness measures. Additionally, the low reliability coefficient
for YEM suggest that our estimates of the association are conservative and thus emphasizes
our findings regarding the association of measures of glycemia to alteration in the material
of the arterial wall. Although we adjusted for known risk factors for cardiovascular disease,
we cannot exclude the possibility of residual confounding in this observational study. These
data were collected approximately 20 years ago (1990–1992), prior to the widespread use of
statins. This likely eliminates any potential confounding effect of statins on the association
between hyperglycemia and arterial stiffness. Our study represents one of the largest
community-based studies of HbA1c and arterial stiffness measures. Additional strengths of
this study include the large sample of persons with and without diabetes, including a large
number of African Americans and the rigorous measurement of major cardiovascular risk
factors.
In conclusion, in this community-based study, HbA1c was significantly and independently
associated with measures of increased arterial stiffness. Our findings suggest that
hyperglycemia contributes to arterial stiffness beyond its effects on atherosis and provide
new evidence that hyperglycemia is associated with altered material within the arterial wall.
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• Elevated HbA1c is associated with measures of increased arterial stiffness
• This association persisted even after accounting for arterial wall thickness.
• Hyperglycemia may contribute to arterial stiffness beyond its effects on
atherosis
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